These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Post-transplant lymphoproliferative disorders, Epstein-Barr virus infection, and disease in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Allen UD, Preiksaitis JK, AST Infectious Diseases Community of Practice. Clin Transplant; 2019 Sep; 33(9):e13652. PubMed ID: 31230381 [Abstract] [Full Text] [Related]
3. [Post-transplant lymphoproliferative disorder: a clinicopathologic study of 15 cases]. Chen DB, Wang Y, Song QJ, Shen DH. Zhonghua Bing Li Xue Za Zhi; 2012 Sep; 41(9):607-12. PubMed ID: 23157829 [Abstract] [Full Text] [Related]
4. Prospective Epstein-Barr virus-related post-transplant lymphoproliferative disorder prevention program in pediatric allogeneic hematopoietic stem cell transplant: virological monitoring and first-line treatment. Chiereghin A, Prete A, Belotti T, Gibertoni D, Piccirilli G, Gabrielli L, Pession A, Lazzarotto T. Transpl Infect Dis; 2016 Feb; 18(1):44-54. PubMed ID: 26574232 [Abstract] [Full Text] [Related]
5. The diverse pathology of post-transplant lymphoproliferative disorders: the importance of a standardized approach. Nalesnik MA. Transpl Infect Dis; 2001 Jun; 3(2):88-96. PubMed ID: 11395974 [Abstract] [Full Text] [Related]
6. Multicenter study of pediatric Epstein-Barr virus-negative monomorphic post solid organ transplant lymphoproliferative disorders. Afify ZAM, Taj MM, Orjuela-Grimm M, Srivatsa K, Miller TP, Edington HJ, Dalal M, Robles J, Ford JB, Ehrhardt MJ, Ureda TJ, Rubinstein JD, McCormack S, Rivers JM, Chisholm KM, Kavanaugh MK, Bukowinski AJ, Friehling ED, Ford MC, Reddy SN, Marks LJ, Smith CM, Mason CC. Cancer; 2023 Mar 01; 129(5):780-789. PubMed ID: 36571557 [Abstract] [Full Text] [Related]
7. Review of Epstein-Barr virus and post-transplant lymphoproliferative disorder post-solid organ transplantation. Lim WH, Russ GR, Coates PT. Nephrology (Carlton); 2006 Aug 01; 11(4):355-66. PubMed ID: 16889577 [Abstract] [Full Text] [Related]
9. Clinicopathologic spectrum and EBV status of post-transplant lymphoproliferative disorders after allogeneic hematopoietic stem cell transplantation. Chen DB, Song QJ, Chen YX, Chen YH, Shen DH. Int J Hematol; 2013 Jan 01; 97(1):117-24. PubMed ID: 23255160 [Abstract] [Full Text] [Related]
10. Presentation and early detection of post-transplant lymphoproliferative disorder after solid organ transplantation. Bakker NA, van Imhoff GW, Verschuuren EA, van Son WJ. Transpl Int; 2007 Mar 01; 20(3):207-18. PubMed ID: 17291214 [Abstract] [Full Text] [Related]
11. The role of quantitative Epstein-Barr virus polymerase chain reaction and preemptive immunosuppression reduction in pediatric liver transplantation: a preliminary experience. Kogan-Liberman D, Burroughs M, Emre S, Moscona A, Shneider BL. J Pediatr Gastroenterol Nutr; 2001 Oct 01; 33(4):445-9. PubMed ID: 11698761 [Abstract] [Full Text] [Related]
12. Post-transplant lymphoproliferative disease in lung transplantation: A nested case-control study. Leyssens A, Dierickx D, Verbeken EK, Tousseyn T, Verleden SE, Vanaudenaerde BM, Dupont LJ, Yserbyt J, Verleden GM, Van Raemdonck DE, Vos R. Clin Transplant; 2017 Jul 01; 31(7):. PubMed ID: 28383790 [Abstract] [Full Text] [Related]
19. Post-transplant lymphoproliferative disorder--case reports of three children with kidney transplant. Spasojević-Dimitrijeva B, Peco-Antić A, Paripović D, Kruscić D, Krstić Z, Cupić M, Cvetković M, Milosevski-Lomić G, Kostić M. Srp Arh Celok Lek; 2014 Jan 28; 142(1-2):83-8. PubMed ID: 24684038 [Abstract] [Full Text] [Related]